Private Equity
Andrea Alms Video: Money In Motion 84 - Ozempic Impact & Walmart Data Mining
November 2023 - Private Equity
TRANSCRIPT Hello, my name is Andrea Alms. I'm technology investor and financial manager And this is your money in motion. Looking back ten years, the S&P biotechnology stocks have been volatile and in certain years on a hot streak. But in the last three years, negative returns. What's going on? We first check out the market size and growth at reports and data.
The global BI biotechnology market was $872 billion in 2021 and has a compound average growth rate of 15.3%. This report includes the growing demand for organic food products, where biotechnology supplies farmers with technology on optimizing output at precedence and research. The market is about 1.2 trillion in 2022 and expected to grow 3.2 trillion by 2030, growing at 12.8%.
At Acumen Research, the global biotechnology market was 372.8 billion in 2021 and estimated to grow to 1.3 trillion by 2030, growing at 15.5%, averaging the averages the market is 415.3 billion, growing at 14.5%. On a next episode, we explore what is going on in the sector, why the index is negative for the last three years. Yet the market size is growing in $1,000,000,000 and a double digit growth rate.
Why is the pie growing and returns shrinking? Thank you. This is your money, your money, in motion.